Cara Therapeutics Inc
F:69C
Cara Therapeutics Inc
F:69C
Price:
1.46
EUR
-2.01%
Market Closed
Market Cap:
€79.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cara Therapeutics Inc
F:69C
|
US |
|
O
|
Orascom Development Holding AG
XBER:4O7
|
CH |
|
XTPL SA
F:5C8
|
PL |
Shareholder Yield
Current shareholder yield for 
69C is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
69C Price
Cara Therapeutics Inc
Cara Therapeutics Inc
Annual Price Range
1.46
52w Low
0.925
52w High
4.04
Price Metrics
| Average Annual Return | -38.62% |
| Standard Deviation of Annual Returns | 38.44% |
| Max Drawdown | -99% |
Shares Statistics
| Market Capitalization | 83.4m EUR |
| Shares Outstanding | 54 680 000 |
| Percentage of Shares Shorted |
N/A
|
69C Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
69C's latest stock split occurred on Jan 2, 2025
The company executed a 1-for-12 stock split, meaning that for every 12 shares held, investors received 1 new share.
Before the split, 69C traded at 0.403 per share. Afterward, the share price was about 4.836.
The adjusted shares began trading on Jan 2, 2025. This was the only stock split in 69C's history.
Pre-Split Price
4.836
0.403
Post-Split Price
4.836
Before
After
